This site is intended for Healthcare Professionals only.

Boots UK to consolidate number of stores in close proximity to each other

Date:

Share post:

Boots UK has unveiled its plan while announcing the Q3 result on Tuesday (27 June), to close 300 stores in ‘close proximity to each other’ over the next year.

“Evolving the store estate in this way allows Boots to concentrate its team members where they are needed and focus investment more acutely in individual stores,” said Seb James, Managing Director, Boots UK and ROI.

Boots has delivered another strong Q3 with retail sales growth of 13.4% for the three months ended 31 May 2023. Its own brand range, offering thousands of quality products at affordable prices, delivered a strong performance, including 40% volume growth in the ‘Everyday’ essentials label.

Its pharmacy sales up 5.7%, the best performance in six quarters. Sales were driven by a good start to hay fever season and over the counter medication, including the launch of new erectile dysfunction range, Eroxon, selling one every 30 seconds on the day of launch.

Boots Online Doctor saw growth of 15%, with sexual health and weight loss amongst the most used services.

The company said: “Boots transformation plan has created a strong and stable platform for growth and will accelerate further, including ongoing investment into the rejuvenation of the store estate. In addition to uplifting existing stores, over the next year Boots will continue to consolidate a number of stores in close proximity to each other.”

James said: “Our focus on offering our customers the best in healthcare and beauty, together with a continued commitment to great value, has been well received, and it is lovely to see more people choosing to shop with Boots. It is particularly pleasing to see our owned brands proving popular, including an exceptional No7 performance. I would like to thank all of our team members for their hard work in delivering these results”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Over half a million dementia cases could go undiagnosed by 2040, study predicts

Currently, an estimated 850,000 people are living with dementia in the UK, with 315,000 undiagnosed cases As the...

GPhC explores potential benefits of covert surveillance powers

GPhc to address ethical concerns regarding covert surveillance, particularly in online pharmacy probes  In a recent minute of meeting,...

UKPPLAB to elevate pharmacist satisfaction and enhance patient safety

PDA advocates pharmacist autonomy in professional leadership amid CPhO influence In a bid to bolster professional leadership within the...

Former NPA director Phil Galt named new Cegedim Rx UK managing director

Phill Galt replaces Adam Dennett who stepped down from the Cegedim Rx's leadership role after a successful ten-year...